340 related articles for article (PubMed ID: 18716874)
21. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn's disease severity.
Gao SQ; Huang LD; Dai RJ; Chen DD; Hu WJ; Shan YF
Int J Clin Exp Pathol; 2015; 8(11):14779-85. PubMed ID: 26823804
[TBL] [Abstract][Full Text] [Related]
22. Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease.
Takaki Y; Mizuochi T; Eda K; Ishihara J; Yamashita Y
Pediatr Int; 2019 Jul; 61(7):720-725. PubMed ID: 31102555
[TBL] [Abstract][Full Text] [Related]
23. The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease.
Chen YH; Wang L; Feng SY; Cai WM; Chen XF; Huang ZM
Gastroenterol Res Pract; 2020; 2020():3467419. PubMed ID: 32655630
[TBL] [Abstract][Full Text] [Related]
24. Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.
Takeyama H; Mizushima T; Iijima H; Shinichiro S; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
Dig Dis Sci; 2015 Nov; 60(11):3418-23. PubMed ID: 26077975
[TBL] [Abstract][Full Text] [Related]
25. Soluble ST2: a new and promising activity marker in ulcerative colitis.
Díaz-Jiménez D; Núñez LE; Beltrán CJ; Candia E; Suazo C; Alvarez-Lobos M; González MJ; Hermoso MA; Quera R
World J Gastroenterol; 2011 May; 17(17):2181-90. PubMed ID: 21633527
[TBL] [Abstract][Full Text] [Related]
26. Enhanced formation of advanced oxidation protein products in IBD.
Krzystek-Korpacka M; Neubauer K; Berdowska I; Boehm D; Zielinski B; Petryszyn P; Terlecki G; Paradowski L; Gamian A
Inflamm Bowel Dis; 2008 Jun; 14(6):794-802. PubMed ID: 18213700
[TBL] [Abstract][Full Text] [Related]
27. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
28. Plateletcrit: a sensitive biomarker for evaluating disease activity in Crohn's disease with low hs-CRP.
Tang J; Gao X; Zhi M; Zhou HM; Zhang M; Chen HW; Yang QF; Liang ZZ
J Dig Dis; 2015 Mar; 16(3):118-24. PubMed ID: 25565427
[TBL] [Abstract][Full Text] [Related]
29. Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease.
Lee EH; Ko JS; Seo JK
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):570-5. PubMed ID: 23752073
[TBL] [Abstract][Full Text] [Related]
30. Serum ghrelin levels in inflammatory bowel disease with relation to disease activity and nutritional status.
Ates Y; Degertekin B; Erdil A; Yaman H; Dagalp K
Dig Dis Sci; 2008 Aug; 53(8):2215-21. PubMed ID: 18080768
[TBL] [Abstract][Full Text] [Related]
31. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
Miranda-García P; Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
[TBL] [Abstract][Full Text] [Related]
32. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.
Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
[TBL] [Abstract][Full Text] [Related]
34. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.
Park JJ; Cheon JH; Kim BY; Kim DH; Kim ES; Kim TI; Lee KR; Kim WH
Dig Dis Sci; 2009 Jul; 54(7):1525-31. PubMed ID: 18975078
[TBL] [Abstract][Full Text] [Related]
35. Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease.
Hisamatsu T; Okamoto S; Hashimoto M; Muramatsu T; Andou A; Uo M; Kitazume MT; Matsuoka K; Yajima T; Inoue N; Kanai T; Ogata H; Iwao Y; Yamakado M; Sakai R; Ono N; Ando T; Suzuki M; Hibi T
PLoS One; 2012; 7(1):e31131. PubMed ID: 22303484
[TBL] [Abstract][Full Text] [Related]
36. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
[TBL] [Abstract][Full Text] [Related]
37. Level of interleukin 17 in inflammatory bowel disease and its relation with disease activity.
Menesy A; Hammad M; Aref S; Abozeid FAM
BMC Gastroenterol; 2024 Apr; 24(1):135. PubMed ID: 38622545
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Ischemia-Modified Albumin in Patients with Inflammatory Bowel Disease.
Guntas G; Sahin A; Duran S; Kahraman R; Duran I; Sonmez C; Calhan T; Sokmen HM
Clin Lab; 2017 Feb; 63(2):341-347. PubMed ID: 28182340
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases.
Matusiewicz M; Neubauer K; Mierzchala-Pasierb M; Gamian A; Krzystek-Korpacka M
Dis Markers; 2014; 2014():643645. PubMed ID: 24803722
[TBL] [Abstract][Full Text] [Related]
40. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]